# Rapid Dose Therapeutics Corp. (RDTCF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RDTCF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 2.78M | $ -4.37M | $ -3.42M | $ 6.07M | $ -6.65M |
| 2024 | $ 1.64M | $ -5.89M | $ -2.49M | $ 2.61M | $ -4.10M |
| 2023 | $ 1.08M | $ -3.72M | $ -1.12M | $ 2.76M | $ -4.54M |
| 2022 | $ 1.44M | $ -10.52M | $ -787.4K | $ 1.60M | $ -1.43M |
| 2021 | $ 1.98M | $ -2.84M | $ -4.67M | $ 1.25M | $ 3.49M |
| 2020 | $ 229.0K | $ -2.89M | $ -612.2K | $ 1.73M | $ -1.33M |
| 2019 | $ 46.3K | $ -19.97M | $ -9.07M | $ 1.29M | $ 851.8K |
| 2018 | $ 2.7K | $ -3.73M | $ -3.17M | $ 0 | $ 5.72M |
| 2017 | $ 0 | $ -70.9K | $ -102.3K | $ 0 | $ -32.2K |
| 2016 | $ 0 | $ -61.6K | $ -41.7K | $ 0 | $ -5.8K |
| 2015 | $ 0 | $ -55.9K | $ -28.8K | $ 0 | $ -20.6K |
| 2014 | $ 0 | $ -46.0K | $ -125.1K | $ 0 | $ -4.2K |
| 2013 | $ 0 | $ -28.8K | $ -17.4K | $ 0 | $ -34.4K |
| 2012 | $ 0 | $ -239.2K | $ -166.1K | $ 0 | $ -12.9K |
| 2011 | $ 0 | $ -84.6K | $ -143.7K | $ 0 | $ 163.6K |
| 2010 | $ 0 | $ -120.2K | $ -26.7K | $ 0 | $ 225.6K |
| 2009 | $ 0 | $ -14.6K | $ -91.6K | $ 0 | $ 134.9K |
| 2008 | $ 0 | $ -6.5K | $ -6.8K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.91 |
| Liabilities / Eq | -1.57 |
| Current Ratio | 0.08 |

## Other views

- [Metrics](https://sponda.capital/en/RDTCF.md)
- [Charts](https://sponda.capital/en/RDTCF/charts.md)
- [Compare](https://sponda.capital/en/RDTCF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.